Minnesota · 2025-2026 Regular Session · Bill
HF 4064: Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HF 4064 is a bill introduced in the Minnesota House on March 9, 2026. According to its official title, it concerns: Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated. Primary sponsor: Liz Reyer (Democratic-Farmer-Labor). It lists 9 additional sponsors. Most recent recorded action (April 20, 2026): Author added Torkelson.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic-Farmer-Labor 7 · Republican 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Liz Reyer | Primary sponsor | Democratic-Farmer-Labor | House | 52A |
| Jeff Backer | Co-sponsor | Republican | House | 9A |
| Kaela Berg | Co-sponsor | Democratic-Farmer-Labor | House | 55B |
| Robert Bierman | Co-sponsor | Democratic-Farmer-Labor | House | 56A |
| Mike Freiberg | Co-sponsor | Democratic-Farmer-Labor | House | 43B |
| Athena Hollins | Co-sponsor | Democratic-Farmer-Labor | House | 66B |
| Anquam Mahamoud | Co-sponsor | Democratic-Farmer-Labor | House | 62B |
| Danny Nadeau | Co-sponsor | Republican | House | 34A |
| Paul Torkelson | Co-sponsor | Republican | House | 15B |
| Bianca Virnig | Co-sponsor | Democratic-Farmer-Labor | House | 52B |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Author added Torkelson
- Introduction and first reading, referred to Health Finance and Policy